CDX2 as a Prognostic Biomarker in Colon Cancer

Coebergh van den Braak, R.R. (Robert R. J), J.W.M. Martens (John) and J.N.M. IJzermans (Jan)

2016-06-02

New England Journal of Medicine , Volume 374 - Issue 22 p. 2182

Additional Metadata
Persistent URL	doi.org/10.1056/NEJMc1602584#SA1, hdl.handle.net/1765/96459
Journal	New England Journal of Medicine
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Coebergh van den Braak, R.R. (Robert R. J), Martens, J., & IJzermans, J. (2016). CDX2 as a Prognostic Biomarker in Colon Cancer. New England Journal of Medicine, 374(22). doi:10.1056/NEJMc1602584#SA1

Publication